US Stock MarketDetailed Quotes

UBX Unity Biotechnology

Watchlist
  • 0.9598
  • -0.0101-1.04%
Close Dec 20 16:00 ET
  • 0.9944
  • +0.0346+3.60%
Post 20:01 ET
16.17MMarket Cap-0.75P/E (TTM)

About Unity Biotechnology Company

Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA.

Company Profile

SymbolUBX
Company NameUnity Biotechnology
Listing DateMay 3, 2018
Issue Price17.00
Founded2009
CEODr. Anirvan Ghosh, PhD
MarketNASDAQ
Employees19
Fiscal Year Ends12-31
Address285 East Grand Avenue
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-416-1192
Websitehttp://www.unitybiotechnology.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Anirvan Ghosh, PhD
  • Director and Chief Executive Officer
  • 2.03M
  • Lynne Sullivan
  • Chief Financial Officer, Principal Accounting Officer and Head of Corporate Development
  • 1.08M
  • Keith R. Leonard, Jr
  • Chairman of the Board
  • 80.75K
  • Dr. Nathaniel E. David, PhD
  • Director
  • 50.75K
  • Camille D. Samuels
  • Independent Director
  • 61.25K
  • Dr. Margo R. Roberts, PhD.
  • Independent Director
  • 54.75K
  • Paul L. Berns
  • Lead Independent Director
  • 88.25K
  • Michael P. Samar
  • Independent Director
  • 60.93K
  • Dr. Gilmore O’Neill, M.B.
  • Independent Director
  • 55.75K
  • Alexander Hieu Nguyen, J.D.
  • General Counsel and Corporate Secretary
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data